Blood Plasma Derivatives Market Growth Outlook Through 2024-2033

Overview and Scope
Blood plasma derivatives are medicinal products crafted from refined proteins found in blood plasma, encompassing clotting factors, albumins, and other proteins employed to treat diverse medical ailments. These derivatives hold significant significance as they aid in replenishing absent or inadequate proteins within the body.

Sizing and Forecast
The blood plasma derivatives market size has grown strongly in recent years. It will grow from $48.26 billion in 2023 to $52.61 billion in 2024 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to increased prevalence of hemophilia and bleeding disorders, growth in geriatric population, increased awareness and diagnosis, rise in surgical procedures, global blood transfusion services.

The blood plasma derivatives market size is expected to see strong growth in the next few years. It will grow to $75 billion in 2028 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to emergence of rare diseases therapies, growth in chronic diseases, increasing healthcare expenditure, patient-centric treatment approaches, growing healthcare infrastructure. Major trends in the forecast period include advancements in fractionation technologies, patient-centric approaches, collaborations and partnerships, expanding applications in neurology, technological innovations in plasma fractionation.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/blood-plasma-derivatives-global-market-report

Segmentation & Regional Insights
The blood plasma derivatives market covered in this report is segmented –

1) By Type: Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, Other Types
2) By Application: Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, Von Willebrand’s Disease, Other Applications
3) By End-User: Hospitals, Clinics, Other End-Users

North America was the largest region in the blood plasma derivatives market in 2023. The regions covered in the blood plasma derivatives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12107&type=smp

Major Driver Impacting Market Growth
The increasing prevalence of immunodeficiency disorders is expected to drive the growth of the blood plasma derivatives market. Immunodeficiency disorders are illnesses that either completely or partially compromise the immune system. Blood plasma derivatives find application in treating a multitude of medical conditions, including immune deficiency disorders. Plasma, a solution consisting of proteins and salts, encompasses over 100 different proteins, among which immunoglobulins are particularly utilized for addressing primary immunodeficiencies. Poor nutrition or malnutrition leads to macro- and micronutrient deficiencies, which can lead to immunodeficiency. For instance, in July 2022, according to another report shared by WHO, globally, 828 million people were impacted by hunger in 2021. Hunger is a major contributor to malnutrition. Therefore, the increasing prevalence of immune deficiency disorders is driving the growth of the blood plasma derivatives market.

Key Industry Players
Major companies operating in the blood plasma derivatives market report are Bayer AG, Sanofi S.A., Takeda Pharmaceutical Company Limited, Baxter International Inc., CSL Limited, Meiji Group, Grifols S.A., Shire Pharmaceuticals Inc., GC Biopharma Corp, Emergent BioSolutions Inc., Shanghai Raas Blood Products Co Ltd., Kedrion S.p.A., Sanquin, Biotest AG, Bio Products Ltd., ADMA Biologics Inc., China Biologic Products Holdings Inc., BioIVT, PlasmaGen BioSciences Pvt. Ltd., Virchow Biotech Private Limited, LFB S.A., Monobind Inc., Intas Pharmaceuticals Ltd., Octapharma Plasma, Fusion Pharmaceuticals Inc.

The blood plasma derivatives market report table of contents includes:

1. Executive Summary
2. Blood Plasma Derivatives Market Characteristics
3. Blood Plasma Derivatives Market Trends And Strategies
4. Blood Plasma Derivatives Market – Macro Economic Scenario
5. Global Blood Plasma Derivatives Market Size and Growth
.
.
.
32. Global Blood Plasma Derivatives Market Competitive Benchmarking
33. Global Blood Plasma Derivatives Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Blood Plasma Derivatives Market
35. Blood Plasma Derivatives Market Future Outlook and Potential Analysis
36. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model